Cargando…
Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis
BACKGROUND: Previous data have shown the tumorigenicity roles of HDAC8 in breast cancer. More recently, the oncogenic effects of this molecule have been revealed in TNBC. The present study aimed to determine the diagnostic value of HDAC8 for the differentiation of TNBC from nTNBC tumors. METHODS: A...
Autores principales: | Menbari, Mohammad-Nazir, Rahimi, Karim, Ahmadi, Abbas, Mohammadi-Yeganeh, Samira, Elyasi, Anvar, Darvishi, Nikoo, Hosseini, Vahedeh, Abdi, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pasteur Institute of Iran
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392136/ https://www.ncbi.nlm.nih.gov/pubmed/32429642 http://dx.doi.org/10.29252/ibj.24.5.283 |
Ejemplares similares
-
Design of a Novel Recombinant Multi-Epitope Vaccine against Triple-Negative Breast Cancer
por: Dariushnejad, Hassan, et al.
Publicado: (2022) -
A photodynamic-mediated glutamine metabolic intervention nanodrug for triple negative breast cancer therapy
por: Yu, Cancan, et al.
Publicado: (2023) -
Injectable click-crosslinked hydrogel containing resveratrol to improve the therapeutic effect in triple negative breast cancer()
por: Shin, Gi Ru, et al.
Publicado: (2022) -
Serum amino acids quantification by plasmonic colloidosome-coupled MALDI-TOF MS for triple-negative breast cancer diagnosis
por: Han, Xinyue, et al.
Publicado: (2022) -
HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
por: Maccallini, Cristina, et al.
Publicado: (2022)